Apollo Hospitals to Consider Q4 & FY26 Results at May 20 Board Meeting
Apollo Hospitals Enterprise Limited has called a Board of Directors meeting on May 20, 2026, to approve standalone and consolidated audited financial results for the three months and year ended March 31, 2026, and to consider a final dividend for FY2025-2026. In compliance with SEBI insider trading regulations, the Trading Window remains closed from April 1, 2026, until 48 hours after the results announcement, i.e., up to May 22, 2026.

*this image is generated using AI for illustrative purposes only.
Apollo Hospitals Enterprise Limited has notified the stock exchanges of an upcoming Board of Directors meeting scheduled for Wednesday, May 20, 2026, to consider the company's Q4 and annual audited financial results for FY26. The intimation, filed under Regulations 29, 42, and 50 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the SEBI (Prohibition of Insider Trading) Regulations, 2015, was issued on May 4, 2026, and signed by S.M. Krishnan, Sr. Vice President – Finance and Company Secretary.
Key Agenda Items for the Board Meeting
The Board of Directors will convene to deliberate on several significant matters pertaining to the company's financial performance for the concluded fiscal year. The following items are on the agenda for the May 20, 2026 meeting:
| Agenda Item: | Details |
|---|---|
| Standalone Financial Results: | Approval of annual audited standalone financial results for the three months/year ended March 31, 2026 |
| Consolidated Financial Results: | Approval of annual audited consolidated financial results for the three months/year ended March 31, 2026 |
| Final Dividend: | Recommendation of final dividend, if any, for the financial year 2025-2026 |
Trading Window Closure
In accordance with the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, and the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window will continue to remain closed for Promoters, Directors, other connected persons, and designated employees of the company. The closure period runs from April 1, 2026, and will remain in effect until 48 hours after the announcement of financial results, i.e., up to May 22, 2026.
This regulatory measure is aimed at preventing insider trading ahead of the disclosure of material financial information. The company has requested both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) to take the intimation on record.
Historical Stock Returns for Apollo Hospitals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.15% | +0.10% | +6.05% | -0.64% | +11.28% | +132.85% |
How might Apollo Hospitals' FY26 annual results reflect the impact of its ongoing hospital expansion strategy and digital health investments on revenue growth and margins?
Will Apollo Hospitals recommend a higher final dividend for FY26 compared to previous years, signaling improved cash flow generation and financial health?
How could Apollo Hospitals' Q4 FY26 performance influence investor sentiment and institutional interest in the broader Indian private healthcare sector?

































